The Helicobacter pΥlori genome - New insights into pathogenesis and therapeutics

New England Journal of Medicine

Volumn 338, Issue 12, 1998, Pages 832-833

  Lee, Adrian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE;

ANIMAL MODEL; ANTIBIOTIC THERAPY; BACTERIAL GROWTH; BACTERIAL INFECTION; EDITORIAL; GASTROINTESTINAL INFECTION; GENOME; GROWTH INHIBITION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PRIORITY JOURNAL; VACCINATION; ARTICLE; BACTERIAL GENOME; GENETICS;

GENOME, BACTERIAL; HELICOBACTER PYLORI;

EID: 0032546151     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199803193381211     Document Type: Editorial

References (5)

1. Cohen J. The genomics gamble. Science 1997;275:767-72.
2. Tomb JH, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.
3. Smith DR. Microbial pathogen genomes - new strategies for identifying therapeutics and vaccine targets. Trends Biotech 1996;14:290-3.
4. Deitsch KW, Moxon KR, Wellems TE. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev 1997;61:281-93.
5. Lee A, Buck F. Vaccination and mucosal responses to Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10:Suppl 1:129-38.